T-One Therapeutics logo
VerifiedBiotechnology Research· Founded 2022

T-One Therapeutics

T-ONE Therapeutics is a pre-clinical biotechnology company pioneering RNA-based medicines that reprogram immune cells to treat cancer and immune-mediated diseases. The company focuses on LINE1-derived RNAs, non-coding transcripts abundantly expressed in dysfunctional T lymphocytes that accumulate in tumors or during aging. By modulating these RNAs with antisense oligonucleotides (ASOs), T-ONE aims to awaken and restore immune function. Building on deep transcriptomic analyses of patient tumors and immune infiltrates, T-ONE is developing first-in-class RNA therapeutics with broad potential across oncology and immunology. Learn more at tonetx.eu

7-day free trial · no credit card

HeadquartersMilano, ItalyEmployees7(1 to 10)Founded year2022Websitetonetx.euLinkedIn profileLinkedIn

Verified contacts

2

available on Kipplo

LinkedIn employees

7

1 to 10 range

Open roles

no listings

Distinct roles

2

indexed titles

Tech stack

0

tools in use

Monthly traffic

organic / mo

Sign up free to see all 2 verified contacts at T-One Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

2 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 1 of 2 verified contacts

Top roles at T-One Therapeutics

2 distinct titles indexed · top 2 shown.

  • 1borea therapeutics srl
  • 1senior research scientist

Sign up to unlock all 2 contacts at T-One Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 2 verified contacts at T-One Therapeutics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

T-One Therapeutics | Kipplo Discover